Thalidomide is a highly effective treatment  of MDS: a single-hospital experience in Japan.
Hayashi
Kunio
K
Hattori
Keiko
K
Toi
Fumiharu
F
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007564:Japan; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D013792:Thalidomide / Q000627:therapeutic use*; D016896:Treatment Outcome
D020533:Angiogenesis Inhibitors; D013792:Thalidomide
Br J Haematol. 2001 Dec;115(4):881-94
11843822
Blood. 2001 Aug 15;98(4):958-65
11493439
Oncologist. 2002;7 Suppl 1:39-49
11961208
Mayo Clin Proc. 2006 Jan;81(1):104-30
16438486
Blood. 2006 Jul 15;108(2):419-25
16609072
Leukemia. 2002 Jan;16(1):1-6
11840256
Blood. 1997 Mar 15;89(6):2079-88
9058730
Ann Hematol. 2005 Jul;84(7):479-81
15800786